Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
Fumitaka Kawakami, Yabata Takatoshi, Etsuro Ohta, et al.
PLoS ONE (2012) Vol. 7, Iss. 1, pp. e30834-e30834
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger, Francesca Tonelli, Genta Ito, et al.
eLife (2016) Vol. 5
Open Access | Times Cited: 931
Alpha-synuclein and tau: teammates in neurodegeneration?
Simon Moussaud, Daryl Jones, Elisabeth L. Moussaud-Lamodière, et al.
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1
Open Access | Times Cited: 250
The role of the LRRK2 gene in Parkinsonism
Jieqiong Li, Lan Tan, Jin‐Tai Yu
Molecular Neurodegeneration (2014) Vol. 9, Iss. 1
Open Access | Times Cited: 223
Genetic predispositions of Parkinson’s disease revealed in patient-derived brain cells
Jenne Tran, Helena Targa Dias Anastacio, Cédric Bardy
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 143
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 110
LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
Isabella Russo, Luigi Bubacco, Elisa Greggio
Journal of Neuroinflammation (2014) Vol. 11, Iss. 1, pp. 52-52
Open Access | Times Cited: 164
Cellular processes associated with LRRK2 function and dysfunction
Rebecca L. Wallings, Claudia Manzoni, Rina Bandopadhyay
FEBS Journal (2015) Vol. 282, Iss. 15, pp. 2806-2826
Open Access | Times Cited: 151
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same
Daniel C. Berwick, George R. Heaton, Sonia Azeggagh, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 144
A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation
Bernard M. H. Law, Victoria A. Spain, Veronica H.L. Leinster, et al.
Journal of Biological Chemistry (2013) Vol. 289, Iss. 2, pp. 895-908
Open Access | Times Cited: 124
Back to the tubule: microtubule dynamics in Parkinson’s disease
Laura Pellegrini, Andrea Wetzel, Simone Grannò, et al.
Cellular and Molecular Life Sciences (2016) Vol. 74, Iss. 3, pp. 409-434
Open Access | Times Cited: 123
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
Dayne Beccano-Kelly, Naila Kuhlmann, Igor Tatarnikov, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 109
Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases
Antonella Sferra, Francesco Nicita, Enrico Bertini
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7354-7354
Open Access | Times Cited: 98
Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
Xi Chen, Jennifer K. Kordich, Erin T. Williams, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 12, pp. 5765-5774
Open Access | Times Cited: 96
Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs
Kurt R. Brunden, Virginia M.‐Y. Lee, Amos B. Smith, et al.
Neurobiology of Disease (2016) Vol. 105, pp. 328-335
Open Access | Times Cited: 91
Pathological Functions of LRRK2 in Parkinson’s Disease
Ga Ram Jeong, Byoung Dae Lee
Cells (2020) Vol. 9, Iss. 12, pp. 2565-2565
Open Access | Times Cited: 70
LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis
A. Raquel Esteves, Russell H. Swerdlow, Sandra M. Cardoso
Experimental Neurology (2014) Vol. 261, pp. 206-216
Open Access | Times Cited: 93
LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
Rachel M. Bailey, Jason P. Covy, Heather L. Melrose, et al.
Acta Neuropathologica (2013) Vol. 126, Iss. 6, pp. 809-827
Open Access | Times Cited: 92
LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
Daniel F. Marker, Jenna M. Puccini, Taryn E. Mockus, et al.
Journal of Neuroinflammation (2012) Vol. 9, Iss. 1
Open Access | Times Cited: 90
LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory
Dayne Beccano-Kelly, Mattia Volta, Lise N. Munsie, et al.
Human Molecular Genetics (2014) Vol. 24, Iss. 5, pp. 1336-1349
Open Access | Times Cited: 90
Microtubule-stabilizing agents as potential therapeutics for neurodegenerative disease
Kurt R. Brunden, John Q. Trojanowski, Amos B. Smith, et al.
Bioorganic & Medicinal Chemistry (2014) Vol. 22, Iss. 18, pp. 5040-5049
Open Access | Times Cited: 89
Neurite Aggregation and Calcium Dysfunction in iPSC-Derived Sensory Neurons with Parkinson’s Disease-Related LRRK2 G2019S Mutation
Andrew J. Schwab, Allison D. Ebert
Stem Cell Reports (2015) Vol. 5, Iss. 6, pp. 1039-1052
Open Access | Times Cited: 79
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation
Bernd K. Gilsbach, Arjan Kortholt
Frontiers in Molecular Neuroscience (2014) Vol. 7
Open Access | Times Cited: 78
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?
Jean‐Marc Taymans, Elisa Greggio
Current Neuropharmacology (2016) Vol. 14, Iss. 3, pp. 214-225
Open Access | Times Cited: 73
LRRK2 Affects Vesicle Trafficking, Neurotransmitter Extracellular Level and Membrane Receptor Localization
Rossana Migheli, Maria Grazia Del Giudice, Ylenia Spissu, et al.
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e77198-e77198
Open Access | Times Cited: 73
The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
Hardy J. Rideout, Leonidas Stefanis
Neurochemical Research (2013) Vol. 39, Iss. 3, pp. 576-592
Closed Access | Times Cited: 72
Page 1 - Next Page

Scroll to top